HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bond, H.M. Articles by Venuta, S. Search for Related Content PubMed PubMed Citation Articles by Bond, H.M. Articles by Venuta, S.

Identification by Differential Display of Transcripts Regulated during Hematopoietic Differentiation

^a Department of Experimental Oncology, National Cancer Institute, Fondazione G. Pascale, Napoli, Italy;
^b Department of Biochemistry and Medical Biotechnology, Federico II University, Napoli, Italy;
^c Department of Hematology-Oncology, Azienda Ospedaliera "Bianchi-Melacrino-Morelli," Reggio Calabria, Italy;
^d Department of Experimental and Clinical Medicine, University of Catanzaro, Italy;
^e CEINGE Advanced Biotechnology, Napoli, Italy

Key Words. Hematopoietic progenitors • Leukemia • Differential display • Polymerase chain reaction • Gene regulation

Prof. S. Venuta, Department of Experimental and Clinical Medicine, Faculty of Medicine, University of Catanzaro, Via T. Campanella Catanzaro, Italy, I-88100.

The polymerase chain reaction-based differential display method (DDRT-PCR) was used to identify mRNAs differentially expressed during the maturation of human CD34⁺ progenitor cells stimulated to differentiate in vitro towards granulomonocytic or erythroid lineages with a mixture of hemopoietins (kit ligand + interleukin 3 + GM-CSF in the absence or presence of erythropoietin, respectively). Three cDNA transcripts (B32, B41, and B56) display differential expression during cytokine-induced maturation of CD34⁺ cells. These clones have no homology with already-described sequences. Primer extension confirmed the presence of the corresponding mRNA. The levels of mRNA corresponding to B32 are enhanced in the later phases of the granulomonocytic as well as in the erythroid differentiation of CD34⁺ cells. The mRNA identified by B41 was induced by a late stage in only granulomonocytic differentiation of CD34⁺ cells. The mRNA corresponding to B56 was instead present in nonstimulated CD34⁺ cells, declined in the early stages of differentiation, and reappeared at later stages in cells treated with both combinations of cytokines. Expression of these genes was detected in a number of acute myelogenous leukemias, as well as in some leukemic cell lines. B32 and B41 were downregulated in KG-1 cells induced to differentiate towards the monocytic lineage, whereas the levels of B56 were unchanged. In K562 cells, clones B41 and B56 were downregulated only in the late phases of PMA-induced megakaryocytic differentiation and during erythroid differentiation. B32 was rapidly downregulated when K562 cells were induced to differentiate towards either megakaryocytic or erythroid phenotypes. These transcripts represent novel hematopoietic cDNAs that should prove of value for the study of human blood cells and their disorders.

This article has been cited by other articles:

				M. Komor, S. Guller, C. D. Baldus, S. de Vos, D. Hoelzer, O. G. Ottmann, and W.-K. Hofmann Transcriptional Profiling of Human Hematopoiesis During In Vitro Lineage-Specific Differentiation Stem Cells, September 1, 2005; 23(8): 1154 - 1169. [Abstract] [Full Text] [PDF]

				H. M. Bond, M. Mesuraca, E. Carbone, P. Bonelli, V. Agosti, N. Amodio, G. De Rosa, M. Di Nicola, A. M. Gianni, M. A. S. Moore, et al. Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse Evi3, is highly expressed in primitive human hematopoietic cells Blood, March 15, 2004; 103(6): 2062 - 2070. [Abstract] [Full Text] [PDF]